Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 392 record(s)

Req # A-2023-001132

OLIVA HORTICULTURE INC. (NEQ: 1178106143). Any defaults, infractions, complaints, amounts unpaid or obligations unmet by the President or the entity; Any notices of non-compliance, orders to cease or suspend work or other similar notices concerning the President or the entity; or Any situations or circumstances that, as time passes, would represent a breach of any legislation or regulations.

Organization: Health Canada

0 page(s)
December 2023

Req # A-2023-001154

Certain information related to the status of the Corporation's file with your organization. Corporation: Umano Medical Sherbrooke Inc. (NEQ: 1164728157) - Address: 670 Joseph-Louis-Mathieu Street, Sherbrooke, Quebec J1R 0X3

Organization: Health Canada

0 page(s)
December 2023

Req # 3025-009-A2022-010

•Provide drafts of the 2021-26 strategic plan, progress reports from the consultant on the strategic plan development and the National Gallery of Canada feedback to the consultants on strategic plan expectations and consultant work. •Include the 2021-22 and 2022-23 follow up assessments and challenges to implementing the 2021-26 strategic plan (including goals met, not met to date) and how this plan has affected and will affect staffing and led to dismissals and could lead to further dismissals. •Provide any records from 2021 and 2022 from Angela Cassie, first as VP Strategic Transformation and now as Interim Director and CEO; Tania Lafreniere, the Vice President of People, Culture and Belonging; and Steven Loft, Vice President of Indigenous Ways and Decolonization in making staff changes and dismissals, and in answering internal and external criticism (including drafts in responding to union, art donors, art galleries and others). Exclude communications with Legal Counsel. •Provide minutes for Board of Trustees meetings since 2019, and staff reports for those meetings concerning the strategic plan, its implementation and staff dismissals. •Exclude records processed under NGC file #A2022-014.

Organization: National Gallery of Canada

1996 page(s)
December 2023

Req # A-2018-001621

Adverse Drug Reactions (ADRs). Report numbers: E2B_01876090, E2B_01338065, E2B_02190267, E2B_01942726, E2B_01475225, E2B_01776362, E2B_01955738, E2B_01940173

Organization: Health Canada

211 page(s)
December 2022

Req # A-2019-001654

Adverse Drug Reactions (ADRs) for PREDNISOLONE. Report numbers: 000719680, E2B_02529865, E2B_02030519, E2B_02515291, E2B_02050563, E2B_02484589, E2B_02564514, E2B_02644290, E2B_02409379, E2B_02405284, E2B_02564514, E2B_02283612, E2B_02288634, E2B_02340759, E2B_02343409, E2B_02110537, E2B_02197044, E2B_02231445, E2B_02094176, E2B_02251355.

Organization: Health Canada

296 page(s)
December 2022

Req # A-2020-000123

Adverse Drug Reaction (ADR). Report number: 000731022.

Organization: Health Canada

4 page(s)
December 2022

Req # A-2020-001368

Adverse Drug Reactions (ADRs) for ENOXAPARIN SODIUM. Report numbers: 000908390, 000912874.

Organization: Health Canada

7 page(s)
December 2022

Req # A-2020-001861

Adverse Drug Reactions (ADRs) for Janumet. Report numbers: E2B_01294965, E2B_01319676, E2B_01387851, E2B_01648958, E2B_00412992, E2B_01322417, E2B_01653190, E2B_00280827.

Organization: Health Canada

472 page(s)
December 2022

Req # A-2021-001526

Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03523213, 953443, E2B_03577001, E2B_03733340, E2B_03526016, E2B_03525423, E2B_03693115, E2B_03698695, E2B_03753478, E2B_03726769, E2B_03578415, E2B_03753511, E2B_03767290, E2B_03736254, E2B_02529659, E2B_03705225, E2B_03791084, E2B_03774153, E2B_03753476.

Organization: Health Canada

1525 page(s)
December 2022

Req # A-2021-001643

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: 000960133, 000958602, 000960030, 000958306, E2B_04307622, 000963494, 000961224, E2B_04231900, 000962867, 000960982, E2B_04241704, 000966094, E2B_04465758, E2B_04459597, E2B_04446085, 000963841, 000961474.

Organization: Health Canada

186 page(s)
December 2022
Date modified: